Abstract: Identification of the specific subset of periodontal ligament-derived mesenchymal stem cells (PDLSCs) will permit the development and improvement of current periodontal regeneration therapy. A popular approach for the isolation of a subset of PDLSCs would be to use cell surface markers to identify these cells, which are effectively enriched in order to isolate stem cells. The CD146 marker is most commonly used to isolate PDLSCs from human periodontal ligament tissues (hPDL). Previous studies have shown that CD146-positive (CD146+) cells possess potencies of high self-renewal and multi-lineage differentiation. However, the capability and potency of mesenchymal stem cells (MSCs) in hPDL-derived CD146-negative (CD146-) cells have not been well established.
Introduction
Periodontal disease is one of the major concern in dentistry because it causes the loss of periodontal tissue, resulting in tooth loss that can cause both functional and aesthetic problems for patients 1) . Once the periodontal ligament tissue (PDL) and alveolar bone are destroyed, it is clinically difficult to recover and reconstruct these three-dimensional tissues because the precise mechanisms that govern this disease and the regenerative processes that restore the lost tissues have not been fully characterized. Many new approaches have been used to facilitate the regeneration of lost or diseased periodontal tissue 2) , but so far, none of these treatments has provided consistently predictable outcomes. Previous studies have led us to speculate that the developing PDL, as well as the mature PDL, contain undifferentiated progenitor cells that are believed to play an important role in the repair of damaged periodontium 3, 4) . The developing PDL retains the potential to differentiate into the cells that constitute the PDL,such as osteoblasts, cementoblasts and fibroblasts [5] [6] [7] . The specific key factors required for the maturation from undifferentiated cells to fully differentiated functional cells have not been elucidated.
Human PDL-derived mesenchymal stem cells (PDLSCs) were first identified by Seo and Shi 8) and were isolated from adult normal impacted third molars. PDLSCs were characterized as highly proliferative cells that were capable of self-renewal, multipotent differentiation in vitro and had the capacity to generate PDL-like structures in vivo 8) . Immunocytochemical staining showed that cultured PDLSC expressed both STRO-1 and CD146 as early mesenchymal progenitor markers 8, 9) . CD146 is one marker that has been employed for the identification of MSCs in PDL cell populations 10) . CD146 is also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein, MUC18, and is currently used as a marker for the endothelial cell lineage 11) . Putative PDLSCs that express the CD14 6 are lo cated predominantly in the perivascular area 12) . Collectively, previous studies have been mainly focused on CD146-positive (CD146 + )
cells within PDL, that have the characteristics of mesenchymal stem cells (MSCs), whereas there is no data on the MSC-like characteristics of CD146 -cells. Only one study 13) From the standpoint of cell transplantation therapy for PDL regeneration, further characterization in the properties of PDLSCs is required. Identification of a specific subset of PDLSCs would expand the current periodontal regeneration therapy 14, 15) . A popular approach to isolate subsets of stem cell populations uses cell surface markers and fluorescence-activated cell sorting (FACS). We previously reported a CD271 + MSC population sorted from deciduous dental pulp 16) . This CD271 + MSC population showed the characteristics of more immature cells in the CD271 -MSC population within dental pulp-derived mesenchymal stem cell (DPMSCs) 16) . To date, no transplantation studies using CD146 markers in PDL cell populations have been carried out although many studies on the transp lantation of unsorted PDL heterogeneous cells has been reported over the last decade 17, 18) . Since any single specific PDLSCs marker is absent, the use of a combination of cell surface markers is necessary. 
Materials and Methods

Cell cultures
In this study, ten human PDL tissue specimens (hPDL) were collected from healthy premolars that were extracted from patients aged 11-36 years for orthodontic reasons (n = 10; two male and eight female donors, average age of 20 years, Table 1 ). The study conformed to the guidelines of the Declaration of Helsinki and the experimental protocol was reviewed and approved by the Ethics Committee at Nihon University School of Dentistry. Informed consent was obtained from all patients prior to donation of the tissue. The PDL was mechanically removed from the middle of the tooth-root surface using surgical scalpels. To exclude contamination from the gingival and apical tissues, the tissue obtained from the coronal and apical regions of the tooth-root was avoided. Tissue fragments were placed in 35-mm tissue culture dishes (Falcon, Lincoln Park, NJ, USA) in alpha-minimal essential medium (α-MEM; Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 20% fetal bovine serum (FBS; Nichirei Biosciences Inc., Tokyo, Japan) and 1% antibiotics (Pen-Strep; GIBCO-Life Technologies, Grand Island, NY, USA) at 37°C in a 95% air/5% CO 2 incubator. When the cells that grew out from the explants had reached pre-confluence, they were harvested and seeded on a 100-mm culture dish (Falcon). All cells were used between the second and third passage in culture.
RNA isolation and reverse transcription-polymerase chain reaction
The hPDL cells were rinsed twice with PBS and total RNA was extracted using RNAiso Plus (Takara Bio Inc., Shiga, Japan) according to the manufacturer's protocol. Following extraction with chloroform (Wako), RNA was precipitated with isopropanol (Wako), rinsed with 75% ethanol (Wako), and redissolved in RNase-free water. The RNA concentration was determined using the Nano Drop1000 (Thermo Fisher Scientific Inc., Yokohama, Kanagawa, Japan).
Reverse-transcription from total RNA was performed using Superscript III® reverse transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. A reaction mixture containing 1 µg of total RNA, 1 µL of random primers (Takara Bio Inc.), 1 µL of dNTP mixture (10 mM) and distilled water in a total volume of 13 µL, were mixed and pre-incubated at 65°C for 5 min. After placing on ice for 1 min, the incubated sample was mixed with 1 µL of Superscript and 35 (Runx2, OSX, ALP, BSP, OC, Col-XVIII, EphrA4, Scleraxis, Tenomodulin) cycles, samples were analyzed by electrophoresis on a 1.5% agarose gel, and were visualized by ethidium bromide staining. The primer sequences for sqPCR are described in Table 2 .
Quantitative real-time polymerase chain reaction (Real-time PCR)
Aliquots of the cDNA samples (2 L) were subjected to realtime PCR using SYBR Green PCR Master Mix (Takara). Realtime PCR was performed in a thermal cycler (C1000 TM Thermal cycler, Bio-Rad Laboratories, Hercules, CA, USA), and the data were analyzed using CFX Manager TM Software (ver.2.1). Realtime PCR cycling conditions used were: 40 cycles at 95°C for 5 s and 60°C for 20 s. Each real-time PCR reaction was performed in triplicate, and the levels of mRNA expression were calculated and normalized to the level of human -actin mRNA.
Phenotype analysis
We analyzed the expression of a panel of nine cell-surface markers on donor cells. 
Colony-forming efficiency assay
CD146+ and CD146-cells were separately seeded at 100 cells/ well in a six-well plate and cultured in growth medium for 7 days.
The cells were fixed with 10% neutral buffered formalin and newly formed colonies were visualized using 0.1% (w/v) toluidine blue (Sigma-Aldrich) staining. Aggregates of more than 50 cells were scored as colonies using light microscopy. The colony-forming efficiency was calculated as the number of colonies relative to the total number of seeded cells in each well.
Cell cycle analysis
CD146
+ and CD146 -cells were cultured in 100-mm culture dishes (1 × 10 5 cells/dish) in growth medium for 3 days, and cell cycle analysis was performed using Click-iT TM EdU Flow Cytometry Assay Kits (Invitrogen/Molecular Probes, Eugene, OR, USA) according to the manufacturer's instructions. In brief, cultured cells were treated for 1 h with 10 mM EdU (5-ethynyl-2'-de-oxyuridine), which is a nucleoside analog of thymidine and is incorporated into DNA during active DNA synthesis. EdUincorporated cells were fixed with paraformaldehyde for 15 min, washed once with BSA/PBS buffer and permeabilized with a saponin-based buffer for 30 min. The cells were then washed once, treated with the click-reaction mixture containing Alexa Fluor 488 azide for 30 min, washed again, and resuspended in PBS buffer.
Next, to measure the DNA content of the cells was measured by staining with CellCycle 488-red in 1% BSA/PBS for 30 min. After staining, the cells were washed twice with PBS and then cell cycle analysis was performed using a FACS Aria (BD Biosciences).
Cell proliferation assays
Cell proliferation was determined by viable cell counting. A total of 1 × 10 4 PDLs were plated in six-well plates and cultured at specific days. After 2, 4, 9 and 16 days, the cells were detached with 0.05% trypsin and the total number of cells was measured using a microscope counting chamber (hemocytometer).
Differentiation into mesodermal lineage cells
The hallmark of MSCs is their ability to differentiate into mesodermal lineage cells. Therefore, we undertook studies to differentiate both CD146 + and CD146 -cells into osteogenic, adipogenic, and chondrogenic lineages.
Osteogenesis
Osteogenic differentiation of hPDL cells were induced as previously described 19) . Briefly, CD146
+ and CD146 -cells were sorted and passaged once in six-well culture plates (1 × 10 4 cells/ well) with growth medium consisting of -MEM supplemented with 10% heat inactivated FBS, 1% Pen-Strep. After reaching 80% confluence, the medium was replaced with osteogenic induction medium; growth medium supplemented with 1 nM dexamethasone (Sigma-Aldrich), 20 mM β-glycerophosphate (Sigma-Aldrich), and 50 μg/mL L-ascorbate phosphate (Wako). The cells were maintained with fresh osteogenic induction medium every 2 days for the indicated period for following analysis.
Cells were cultured in osteogenic medium or growth medium for 3 days and the mRNA was then extracted. Real-time PCR was used to analyze the level of mRNA expression of Runx2, BSP, ALP and OSX. (Table 2) After culture for indicated days, cells were fixed 10% neutral buffered formalin for 15 min. Subsequently, cultures were washed twice with PBS and stained with alkaline phosphatase (ALP) activity staining solution, pH 9.5 (NBT/BCIP ready-to-use tablets; Roche Diagnostics, Penzberg, Germany) for 15 min or a saturated solution of Alizarin Red-S (pH 4.0) for 5 min. Cells were washed with distilled water, and examined under a light microscope or an EPSON scanner, GT-X800 (EPSON, Tokyo, Japan).
Ca
2+ accumulation was determined by measuring Ca 2+ uptake into the cell culture at 21 days. The culture supernatant was removed and cells were washed with PBS, 1 M HCl solution was added to each well and 500 μL of distilled water was added to each well. The amount of Ca 2 + was determined using the Calcium E-test (Wako) according to the manufacturer's instructions.
Adipogenesis
CD146
+ and CD146 -cells were cultured in six-well culture plates (5 × 10 3 cells/well) with growth medium. After reaching 90% confluence, the medium was replaced with adipogenic induction medium: -MEM supplemented with 10% FBS, 1 µM dexamethasone (Sigma-Aldrich), 170 nM insulin (Sigma-Aldrich), 0.2 mM indometh acin (Sigma-Aldrich), and 0.45 mM isobutylmethylxanthine (Sigma-Aldrich) and the cells were cultured for 21 days 19) . Lipid vacuole formation in the adipogenic cultures was determined by Oil Red O staining on day 21. The cells were fixed with 10% neutral buffered formalin for 15 min, rinsed with distilled water, and incubated with 60% isopropanol for 1 min. The cells were stained with the Oil Red O working solution (30 mL of 3 mg/mL Oil Red O/isopropanol stock solution and 20 mL of distilled water) for 15 min at 37°C. The cultures were observed with phase contrast microscopy (ECLIPSE TS100, Nikon, Tokyo, Japan). mRNA was extracted for gene expression analysis from both cell populations cultured in adipogenic or growth medium for 7 days. Real-time PCR was used to analyze mRNA expression of PPARγ, ADD1 and adiponectin. (Table 3 )
Chondrogenesis
The chondrogenic potential of CD146 + and CD146 -cells was examined in pellet cultures. Cell pellets were collected in centrifuge tube (2.5 × 10 5 cells/tube) with growth medium. After 
Runx2
F Control groups were exposed to -MEM and 1× InsulinTransferrin-Selenium-A for 28 days.
The microscopic structure of cells was examined after cell pellets were fixed in 10% neutral buffered formalin, dehydrated in a series of ethanol, embedded in paraffin, and cut into 7 μm sections. After deparaffinization of the sections they were stained with either hematoxylin and eosin (H&E) or Alcian Blue. The glycosaminoglycan (GAG) content was also determined using a sulfated GAG assay kit (Biocolor Ltd., County Antrim, UK). DNA content was determined using a fluorescent DNA quantification kit (Bio-Rad Laboratories, Hercules, CA, USA). Cells were cultured in chondrogenic medium or growth medium for 7 days.
Real-time PCR was used to analyze mRNA expression of COMP. 
Results
Characterization of hPDL cells
In primary culture of a hPDL explant, spindle-shaped cells migrated away from the explant and these cells appeared high proliferative (Fig. 1A) . mRNA levels of osteogenic and tenogenesis-related genes were analyzed by sqPCR at the third passage of cell population (Fig. 1B ) that had been used in previous experiments [20] [21] [22] . The mRNA expression of the osteogenic (Runx2, Osx, ALP, BSP, OCN, Col-I, Col-III) and tenogenic (Col-XII Col-XVIII, EPHrA4, Periostin, Scleraxis, Tenomodulin and Mohawk) genes were all detected (Fig. 1C) .
A panel of cell surface markers were assayed for their expression on hPDL cells (Fig. 2) . The hematopoietic markers, CD34 and CD45 were negative, whereas common BMSC markers (CD44, CD73, CD90) were positive (> 90% positive cells). The expression levels of CD271, STRO-1, and SSEA4 were low (Fig.  2) .
CD146 has been used to identify or isolate the PDLSCs in PDL. Therefore, the proportion of CD146 + cells in PDL cells was also examined. While the expression of CD146 showed marked variability between donors, the average number of CD146 + cells was 49.1% ± 12.4% in hPDL cells (Table 1) .
Stability of CD146 expression
PDL cells were sorted into two cell populations with higher CD146 expression (19.6 %) (CD146 + ) and lower CD146 expression (16.7 %) (CD146 -), see Fig. 3 -A. After sorting, the stability of CD146 expression in long-term culture and in the culture of seventh-passage cells was examined in growth medium. FACS analysis showed that the proportion of CD146 + cells was 85.1% at 30 days of culture and 50.8% at 50 days of culture with one passage. CD146 expression was also detected at a lower level in the CD146-cells (Fig. 3B) . Surprisingly, in one donor out of ten, the initial cell samples sorted as CD146 -showed a higher p ro po rt io n of C D1 4 6 + ce ll s al t er ( d a ta n o t sh o wn) . In contrast, after five or six passages (P5 or P6), the proportion of CD146 + cells in the CD146 + cell population was over 90% in two samples but one out of three donors showed a much lower proportion of CD146 + cells (8.5%) ( Table 1) .
Characteristics of CD146 + and CD146 -cells
Clonogenic and growth potential
The single cell-derived colony-forming efficiency and cell proliferation assay were successfully performed in five samples (Figs. 4 and 5) . The colony-forming efficiency of CD146 + cells was found to be significantly higher at approximately twice that of CD146 -cells in four samples (Fig. 4B) . There was no significant difference in one sample (data not shown). Both cell populations possessed replicative potential.
Cell proliferation analysis showed that the growth potential of CD146 + cells was higher than that of CD146 -cells at day 16 with a significant difference observed in four samples (Fig. 5A) . Furthermore, cell cycle analysis showed that the CD146 + cell population contained a significantly higher percentage of cells in S and G2M phases than the CD146 -cell population in two samples (Fig. 5B) .
Osteogenic differentiation potential
The osteogenic differentiation potential of the CD146 + and CD146 -cells was determined at the indicated days by ALP and Alizarin Red-S staining. ALP activity clearly increased with time in both cell populations with or without differentiation-inducing medium. After 3 days of culture in the osteogenic medium CD146 + cells showed more intense ALP activity than any other cells (Fig.  6A) . CD146 + cells in the osteogenic medium showed the formation of positive Alizarin Red-S-staining nodules after 14 days in culture and obvious accumulation of mineralized nodules in osteogenic medium at 21 days by phase-contrast microscopy. The accumulation of mineralized nodules in CD146 -cells in osteogenic medium was barely discernible (Fig. 6B) . Interestingly, both
CD146
+ and CD146 -cells under growth medium condition did not accumulate Ca 2+ in the culture medium even though ALP staining was clearly positive (Fig. 6B) . To quantify mineral formation, the Ca 2+ content of the culture was calculated. The mineral content dramatically increased and there was a significant difference in the Ca 2+ content in osteogenic medium at 21 days (Fig. 6C) .
Real-time PCR analysis demonstrated an increased expression of Runx2 and ALP in CD146 + cells compared with CD146 -cells (Fig. 6D) . The levels of expression of Runx2 and ALP mRNAs but not Osterix and BSP mRNAs were significantly higher (P < 0.05) in CD146 + cells than in CD146-cells in osteogenic medium.
The stability of CD146 expression was examined in both cell populations under in both growth medium and osteogenic medium.
The proportion of CD146 + cells in CD146 + cell population after osteogenic induction for 28 days was over 20% but the proportion of CD146 + cells in any other population was less than 6% (Fig.  7A) .
Adipogenic differentiation potential
The accumulation of lipid vacuoles as determined by positive Oil-Red O staining was observed within the cytoplasm in all CD146 + cell samples when subjected to adipogenic differentiation (Fig. 7A) . Surprisingly, this positive staining was observed in three out of five CD146 -cell donors (Table 5) Real-time PCR analysis also demonstrated increased expression of an adipocyte-specific marker (adiponectin) and two adipocyte differentiation transcripts (ADD1 and PPARγ) (Fig. 7B ). In addition, the stability of CD146 expression was examined after adipogenic induction for 28 days. The proportion of CD146 + cells in the CD146 + cell population cultured in adipogenic medium was greater than 20% but the proportion of CD146 + cells in any other cell population was less than 3% by FACS analysis (Fig. 8B) .
Chondrogenic differentiation potential
To determine whether CD146 + and CD146 -cells are capable of differentiating into chondrogenic lineage cells, both cell populations were maintained in pellet cultures for 28 days. The newly synthesized glycosaminoglycan (GAG) component of cartilage-specific proteoglycan, showed positive Alcian Blue staining in both CD146
+ and CD146 -cell pellets that were cultured in chondrogenic induction medium (Fig. 9A) . In contrast, noninduced CD146 + and CD146 -pellets displayed no staining of GAG.
The GAG content in CD146 -cells was compared to CD146 + cells cultured in chondrogenic induction medium for 28 days (Fig. 9B ).
Interestingly, the GAG level in CD146 -pellets was significantly In particular, STRO-1 9) and CD146 have been used as markers for the selection of PDLSCs 8, 12, 13) . In contrast, we have not been higher than for CD146 + pellets. Furthermore, gene expression of cartilage oligomeric matrix protein (COMP) as a glycoprotein in the CD146 -cell pellet was also significantly higher than in the CD146 + cell pellet (Fig. 9C ). There was no significant difference in gene expression for Sox9 and Col II (data not shown).
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Discussion
Recent studies have shown that the transplantation of PDL cells may be essential for PDL regeneration 23, 24) . Significant The GAG content of the pellets was measured. Each bars indicated the mean ± standard deviation (SD) (n = 6, * P < 0.05) (C) The pellets were cultured in growth medium (ind (-)) or chondrogenic medium (ind (+)) for 7 days and mRNAs were extracted. Real-time PCR was used to analyze mRNA expression of the indicated chondrogenic marker (COMP). Each bars indicated the mean ± standard deviation (SD) (n = 3, * P < 0.05).
able to detect STRO-1 expression in PDL cells, which is consistent with other reports 25, 26) .
In this study, we investigated the utility of CD146 as surface maker to isolate the required subset of PDLSCs. CD146/MCAM has been shown to play a role in cell-to-cell adhesion [27] [28] [29] [30] [31] . The function of CD146 in lymphocytes has been demonstrated through the interaction of MCAM-1 with the actin cytoskeleton, which leads to the formation of microvilli 11, 32, 33) . In contrast, the function of CD146 in PDLSCs is relatively poorly understood and its suitability as a PDLSCs marker has not been established. In order to characterize CD146 in PDLSCs, we investigated sorted cells with higher intensity of CD146 expression (CD146 + cells) and those with lower intensity of CD146 expression (CD146 -cells). The average proportion of CD146 + cells in PDL from ten patients was approximately 50 ", but there was some interindividual variability. Previous studies have found that the proportion of CD146 + cells in PDL varied from 21% 34) to 60% 13) , and they were 37% in HUVEC, 66% in pericytes, and 73% in MSC from bone marrow 35) . In this study, the stability of CD146 expression was examined after culture for 30 days and 50 days.
After the CD146 + cells were sorted and cultured for 30 days with one passage in growth medium, the proportion of CD146 + cells remained over 80% and the cultured cells were pre-confluent. At day 50, the proportion of CD146 + was greatly decreased to 50%
and the cultured cells were over-confluent. These results suggest that the condition of the cultured cells influences CD146 expression in PDL cells. Furthermore, after the sorted CD146 + cells were passaged three times while they were under 50% confluence, the proportion of CD146 + cells was maintained at over 90% with only one sample that lost CD146 expression (data not shown). In contrast, the proliferation activity of CD146 -cells was greatly decreased after several passages (data not shown). These results suggest that the CD146 expression is regulated during cell growth in hPDL cells, but this study did not directly investigate . Our experimental data suggest that the environment in differentiation medium may support the asymmetrical dividing of PDLSCs, which results in the production of CD146 + cells through the self-renewal potential of these cells.
This study examined the utility of CD146 expression in hPDL cells and showed that the CD146 marker is indeed useful for isolating cells with osteogenic or chondrogenic potential. Our results raise another major question. Is using either CD146 + or CD146 -cells preferable for PDL regeneration? PDLSCs need to produce either non-calcified PDL or calcified tissues such as cementum and bone. Therefore, we are attempting to transplant both cell populations into PDL defects to answer this question.
The findings from these studies will support the potential utility of PDLSCs for cell-based therapeutic applications. [36] [37] [38] . The detachment of PDL cells from their in vitro niche may result in a change in their environment at the maturation stage, which consequently induces CD146 expression 39) . Recently, a new concept has been suggested that the state of "stemness" may be transient and reversible rather than a fixed property that develops following interaction with the environment [40] [41] [42] . This concept is applicable to PDLSCs obtained in this study as a fundamental property of MSCs.
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